Engineered nanoparticles circumvent the adaptive treatment tolerance to immune-checkpoint blockade therapy
Crossref DOI link: https://doi.org/10.1007/s11426-019-9588-4
Published Online: 2019-08-29
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guo, Weisheng
Liu, Lu
Xiang, Chenyang
Chen, Jingqi
Liang, Xing-Jie
Text and Data Mining valid from 2019-08-29
Version of Record valid from 2019-08-29
Article History
Received: 3 June 2019
Accepted: 16 August 2019
First Online: 29 August 2019